Future Market Insights opines that the neotame market is positioned for accelerated reformulation-driven growth, where EFSA's July 2025 five-fold increase in Acceptable Daily Intake from 2 to 10 mg/kg body weight is unlocking usage levels previously constrained by regulatory headroom limitations in European beverage and bakery applications.